Status:
COMPLETED
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
Brief Summary
The purpose of this study is to assess the safety of long-term treatment with Ozempic® in patients with type 2 diabetes mellitus. People will get Ozempic® as prescribed by their doctor. People will be...
Eligibility Criteria
Inclusion
- Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- The decision to initiate treatment with commercially available Ozempic® has been made by the patient/Legally Acceptable Representative (LAR) and the treating physician before and independently from the decision to include the patient in this study.
- Patients with Diabetes Mellitus, Type 2 (T2DM) who the physician has decided to start treatment with Ozempic®.
- Male or female, no age limitation.
Exclusion
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
- Patients who fall under contraindications to the label.
- Patients who are or have previously been treated with Ozempic®.
- Female who is pregnant, breast-feeding or intends to become pregnant.
Key Trial Info
Start Date :
July 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 12 2025
Estimated Enrollment :
3217 Patients enrolled
Trial Details
Trial ID
NCT04469855
Start Date
July 27 2020
End Date
May 12 2025
Last Update
December 31 2025
Active Locations (414)
Enter a location and click search to find clinical trials sorted by distance.
1
Seino Internal Medicine Clinic_Internal medicine
Koriyama-shi, Fukushima, Fukushima, Japan, Japan, 963-8851
2
Tsuruma Kaneshiro Diabetes Clinic_Internal medicine
Yamato-shi, Kanagawa, Japan, 242-0004
3
Takai Medical Clinic_Internal Medicine
Kamakura-shi, Kanagawa, Kanagawa, Japan, Japan, 247 0056
4
Matsuba Clinic_Internal Medicine
Kawasaki-shi, Kanagawa, Japan, Japan, 212 0024